口腔鳞状细胞癌辅助治疗后PET/CT显像的临床影响
这项单中心回顾性研究比较了口腔鳞状细胞癌辅助治疗后经PET/CT发现症状性复发(A组)与经定期PET/CT监测发现无症状复发(B组)的临床结局,B组2年疾病特异性生存率和总生存率高于A组(P=0.073和P=0.025),定期PET/CT监测有助于早期发现无症状复发。
要点
- B组2年疾病特异性生存率和总生存率高于A组,P值分别为0.073和0.025。
- 与总生存相关的时间依赖性ROC曲线分析显示,PET/CT阳性发现时间的最佳截断值A组为12个月,B组为9个月。
- 多因素分析确定的独立危险因素用于构建各研究组2年疾病特异性生存率和总生存率的预后评分系统(均P<0.001)。
核心结论
- 定期PET/CT监测是早期发现具有复发危险因素的无症状口腔鳞状细胞癌患者复发灶的有价值工具。
- 存在临床症状和PET/CT阳性发现时间短是晚期口腔鳞状细胞癌患者临床结局的不良预后因素。
- 根据所构建的预后评分系统,在各患者亚组中讨论了挽救治疗的优先级。
研究设计与样本
- 这项单中心回顾性研究基于前瞻性收集的数据,纳入111例根治性切除后接受辅助治疗并出现复发的晚期口腔鳞状细胞癌患者,其中A组51例,B组60例。
- 以组织病理学作为复发灶的金标准,采用Kaplan-Meier曲线和Cox比例风险回归模型分析辅助治疗后PET/CT监测的影响。
主要发现
- B组2年疾病特异性生存率和总生存率高于A组,P值分别为0.073和0.025。
- 时间依赖性ROC曲线分析显示,与总生存相关的时间至PET/CT阳性发现的最佳截断值A组为12个月,B组为9个月。
- 多因素分析确定的独立危险因素用于构建各研究组2年疾病特异性生存率和总生存率的预后评分系统(均P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This single-center retrospective study of prospectively collected data was aimed at comparing the clinical outcomes of positron emission tomography/computed tomography (PET/CT) for patients with oral cavity squamous cell carcinoma (OSCC) with symptomatic recurrences identified by PET/CT imaging following adjuvant therapy (Group A) versus those of cases with asymptomatic recurrences diagnosed through periodic post-adjuvant therapy PET/CT surveillance (Group B). We also sought to establish the priority of salvage therapy in the two study groups. METHODS: We identified 111 patients with advanced resected OSCC who developed recurrences following adjuvant therapy (51 in Group A and 60 in Group B). Histopathology served as the gold standard for recurrent lesions. The impact of post-adjuvant therapy PET/CT surveillance was examined with Kaplan-Meier curves and Cox proportional hazards regression models. RESULTS: The 2-year DSS and OS rates were marginally or significantly higher in Group B than in Group A (P = 0.073 and P = 0.025, respectively). Time-dependent ROC curve analysis demonstrated that the optimal cutoff values for time to positive PET/CT findings in relation to OS were 12 months for Group A and 9 months for Group B, respectively. Independent risk factors identified in multivariate analyses were used to devise two prognostic scoring systems for 2-year DSS and OS in each study group (all P < 0.001). CONCLUSIONS: Scheduled periodic PET/CT surveillance is a valuable tool for early detection of recurrent lesion(s) in asymptomatic OSCC patients who bear risk factors for disease recurrence. The presence of clinical symptoms and a short time to positive PET/CT findings were adverse prognostic factors for clinical outcome in patients with advanced OSCC. The priority of salvage therapy is discussed in each patient subgroup according to the devised prognostic scoring systems.
引用
- Lin HC, Kang CJ, Huang SF, et al. Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2017. PMID: 28547178. doi:10.1007/s00259-017-3713-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。